FI871447A - Stabila injicerbara antivomitiva kompositioner. - Google Patents

Stabila injicerbara antivomitiva kompositioner. Download PDF

Info

Publication number
FI871447A
FI871447A FI871447A FI871447A FI871447A FI 871447 A FI871447 A FI 871447A FI 871447 A FI871447 A FI 871447A FI 871447 A FI871447 A FI 871447A FI 871447 A FI871447 A FI 871447A
Authority
FI
Finland
Prior art keywords
injicerbara
antivomitiva
kompositioner
stabila
water
Prior art date
Application number
FI871447A
Other languages
English (en)
Other versions
FI871447A0 (fi
Inventor
Munir N Nassar
Shreeram N Agharkar
Joseph B Bogardus
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/019,733 external-priority patent/US4882356A/en
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of FI871447A0 publication Critical patent/FI871447A0/fi
Publication of FI871447A publication Critical patent/FI871447A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI871447A 1986-04-07 1987-04-02 Stabila injicerbara antivomitiva kompositioner. FI871447A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84861586A 1986-04-07 1986-04-07
US07/019,733 US4882356A (en) 1987-03-10 1987-03-10 Stable injectable antiemetic compositions

Publications (2)

Publication Number Publication Date
FI871447A0 FI871447A0 (fi) 1987-04-02
FI871447A true FI871447A (fi) 1987-10-08

Family

ID=26692535

Family Applications (1)

Application Number Title Priority Date Filing Date
FI871447A FI871447A (fi) 1986-04-07 1987-04-02 Stabila injicerbara antivomitiva kompositioner.

Country Status (19)

Country Link
EP (1) EP0241837B1 (fi)
KR (1) KR900002745B1 (fi)
CN (1) CN87103415A (fi)
AT (1) ATE70716T1 (fi)
AU (1) AU597955B2 (fi)
CA (1) CA1282703C (fi)
CS (1) CS265238B2 (fi)
DE (1) DE3775445D1 (fi)
DK (1) DK175787A (fi)
EG (1) EG18407A (fi)
ES (1) ES2038134T3 (fi)
FI (1) FI871447A (fi)
GR (1) GR3003636T3 (fi)
HU (1) HU198622B (fi)
IL (1) IL82122A0 (fi)
NO (1) NO871434L (fi)
NZ (1) NZ219890A (fi)
PT (1) PT84635B (fi)
ZW (1) ZW6287A1 (fi)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5561161A (en) * 1994-03-25 1996-10-01 Oxigene, Inc. Methods of administering and pharmaceutical formulations containing n-substituted benzamides and/or acid addition salts thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2731013C2 (de) * 1977-07-08 1982-07-15 Lentia Gmbh Verfahren zur Herstellung einer wäßrigen Infusionslösung
EP0008525A3 (en) * 1978-08-25 1980-05-28 Beecham Group Plc Pharmaceutical compositions and process for their preparation
JPS599539B2 (ja) * 1979-11-13 1984-03-03 日本化薬株式会社 ニトログリセリン水溶液及びその製造法
US4328213A (en) * 1979-11-28 1982-05-04 Schering Corporation Stable injectable labetalol formulation
GB8412585D0 (en) * 1984-05-17 1984-06-20 Beecham Group Plc Composition
US4808624A (en) * 1984-06-28 1989-02-28 Bristol-Myers Company Pharmacologically active substituted benzamides
EP0201537B1 (en) * 1984-10-23 1992-04-29 Nastech Pharmaceutical Company, Inc. Novel use of anti-nausea and anti-emetic pharmazeutical agents.

Also Published As

Publication number Publication date
DK175787D0 (da) 1987-04-06
HU198622B (en) 1989-11-28
CS247287A2 (en) 1989-01-12
EP0241837A3 (en) 1989-05-10
ZW6287A1 (en) 1987-09-23
GR3003636T3 (fi) 1993-03-16
CN87103415A (zh) 1988-01-20
CS265238B2 (en) 1989-10-13
FI871447A0 (fi) 1987-04-02
HUT43489A (en) 1987-11-30
EP0241837A2 (en) 1987-10-21
IL82122A0 (en) 1987-10-30
CA1282703C (en) 1991-04-09
NO871434L (no) 1987-10-08
KR900002745B1 (ko) 1990-04-28
EG18407A (en) 1993-02-28
EP0241837B1 (en) 1991-12-27
PT84635B (pt) 1989-11-30
ATE70716T1 (de) 1992-01-15
DE3775445D1 (de) 1992-02-06
ES2038134T3 (es) 1993-07-16
DK175787A (da) 1987-10-08
AU597955B2 (en) 1990-06-14
AU7115987A (en) 1987-10-08
PT84635A (en) 1987-05-01
NO871434D0 (no) 1987-04-06
NZ219890A (en) 1990-07-26
KR870009714A (ko) 1987-11-30

Similar Documents

Publication Publication Date Title
DE69027235D1 (de) Xanthinderivate
ES2167720T3 (es) Compuestos de 1-fenilpirazol y aplicaciones medicinales de los mismos.
DK506587D0 (da) Imidderivater
IT1152287B (it) Pirrolidin-derivati
DK397383A (da) 2-nitro-1,1-ethendiaminer, fremgangsmaader til fremstilling deraf samt deres anvendelse som laegemidler
IE45051L (en) Quinazolines
NO892939D0 (no) Fremgangsmaate til fremstilling av bu-3608-derivater.
ATE122669T1 (de) Zearalanol-derivate mit anabolytischer wirkung.
MX13723A (es) Procedimiento para preparar derivados de 9-desoxo-9a-alil- y propargil-9a-aza-9a-homoeritromicina a
FI871447A (fi) Stabila injicerbara antivomitiva kompositioner.
NO903430L (no) Fremgangsmaate for fremstilling av aminoketonderivater.
DE69828390D1 (de) Diaminotrifluoromethylpyrimidinderivate enthaltende antikrebs-zusammensetzung
DE69925250D1 (de) Aktivatoren der kalium-kanäle
DK423186D0 (da) Spiro-(benzofuran-2(3h),1`cycloheptan)-derivater, deres fremstilling og anvendelse samt mellemprodukt til fremstillingen
ES2195309T3 (es) Derivados de tetrahidrofurano.

Legal Events

Date Code Title Description
FD Application lapsed
FD Application lapsed

Owner name: BRISTOL-MYERS SQUIBB COMPANY